Description
âš Side Effects and Precautions
😴 Most Common Side Effects
- Nausea or vomiting
- Heartburn or stomach upset
- Diarrhea or mild abdominal pain
- Dizziness or mild drowsiness
- Loss of appetite Important Safety Precautions
- Stomach Ulcers: Avoid this medication if you have active gastric ulcers or gastrointestinal bleeding.
- Liver & Kidney Safety: Paracetamol processed in high amounts stresses the liver. Avoid alcohol while taking this medicine to prevent toxic liver damage
- Double-Dosing Risks: Do not take other cold, flu, or pain relief pills containing paracetamol concurrently, as an accidental overdose can result in severe liver complications.
- Pregnancy: This drug is generally contraindicated during pregnancy and breastfeeding unless explicitly cleared by a doctor due to potential fetal risks.
- Would you like to know more about the ideal dosage schedule or how it interacts with other medications like blood thinners?
Powerful Relief for Pain and Inflammation
Aceclofenac, Paracetamol & Serratiopeptidase Tablets I.P offer a trusted combination to manage pain, reduce inflammation, and alleviate discomfort effectively. Designed to promote faster recovery, these tablets provide relief from various acute and chronic conditions, helping you regain mobility and improve your quality of life.
Advanced Triple-Action Formula
This formulation uniquely combines Aceclofenac for its anti-inflammatory properties, Paracetamol for effective pain relief, and Serratiopeptidase as an enzyme to reduce swelling and accelerate healing. Together, these ingredients work synergistically to deliver enhanced therapeutic benefits, tailored to address your specific health needs.
Trusted Choice for Everyday Use
Recommended and relied upon by healthcare professionals, these tablets are ideal for managing conditions like arthritis, postoperative pain, and musculoskeletal disorders. Crafted with care and guided by stringent quality standards, they ensure safety and efficacy for consistent results.





Reviews
There are no reviews yet.